Decheng Capital
Silicon Valley · Seed–Growth · 13 people tracked
Investment thesis
Decheng Capital invests in life sciences companies globally, leveraging deep expertise across biotech, medtech, and digital health sectors. The firm maintains a significant presence across Silicon Valley, Shanghai, and New York, positioning it to identify and support exceptional life sciences entrepreneurs across major innovation hubs.
Source: firm website, verified Jul 20, 2026.
Team · 13 people
from the firm's websiteWhat they invest in
from 9 of 38 portfolio companiesBiotech ×5AI & Machine Learning ×4Deep Tech ×2Enterprise Software ×2Medical Devices ×2SaaS ×2Advanced Manufacturing ×1Consumer ×1
HQs:United States×6Canada×1
Investments · 38 tracked
founders shown can be your intro pathCellares develops automated manufacturing systems and technology platforms to accelerate the production and commercialization of cell therapies. The company serves biopharmaceutical manufacturers and cell therapy developers worldwide.
Advanced ManufacturingBiotechMedical DevicesSouth San Francisco, US
Fabian Gerlinghaus(Co-Founder and Chief Executive Officer)Omar Kurdi(Co-Founder and President)
Company that went public on NASDAQ in 2019 (ADPT)
Company that went public on HKSE in 2020 (1952)
Biopharmaceutical company that went public on NASDAQ in 2021 (AADI)
Company that went public on NASDAQ in 2024 (CGON)
Company that went public on NASDAQ in 2021 (HLTH)
Employment Hero is an AI-powered employment operating system that provides payroll, HR, recruitment, and benefits management software for Canadian businesses. The company also offers HeroForce, a managed employment infrastructure service enabling hiring and employment of talent across 180+ countries.
AI & Machine LearningEnterprise SoftwareFintechHR TechSaaSToronto, CA
Biopharmaceutical company that went public on NASDAQ in 2015 (HKSE: 1530)
Company that went public on NASDAQ in 2016 (NVTA)
Company that went public on SHA in 2019 (688108)
Company that went public on HKSE in 2017 (1789)
Mammoth Bio develops technology to read and write the code of life, operating in the biotechnology sector.
BiotechDeep TechMedical DevicesBrisbane, US
Jennifer Doudna(Founder)Trevor Martin(Co-founder, Chief Executive Officer)Janice Chen(Co-founder, Chief Scientific Officer & President, Research)Lucas Harrington(Co-founder)
Mirvie develops an RNA-based platform for early detection of pregnancy complications, enabling proactive intervention before complications become critical. The platform serves pregnant women and their healthcare providers to improve maternal and fetal health outcomes.
BiotechFemTechHealthtech
Acquired entity; parent company went public on NYSE (NUVB)
Remix provides an AI-powered management system that uses existing camera infrastructure to detect operational issues like long lines and inventory problems in real-time, then automatically routes fixes to staff with clear instructions and video evidence. The product targets multi-location restaurant and retail operations to reduce manager overhead and compliance costs while maintaining consistent standards.
AI & Machine LearningEnterprise SoftwareRetail TechPleasant Hill, US
Remix is a mobile app that allows users to remix videos by pasting video links, adding photos, and instructing the app to make edits. It serves content creators and social media users who want to easily modify and customize video content.
ConsumerCreator EconomySan Francisco, US
Sam Kaplan(Founder)in
Remix is a platform for public transit agencies to plan, schedule, and visualize transit systems in real-time. It enables collaboration among teams, data-driven decision-making, and multi-modal network management for transit agencies.
GovTechLogistics & Supply ChainSaaSSan Francisco, US
Tiffany Chu(CEO & Cofounder)inSam Hashemi(Founder/CEO)inDaniel Getelman(Founder/CTO)inDanny Whalen(Founder)in
Remix Therapeutics develops RNA reprogramming technology to treat various diseases and disorders. The company applies precision medicine approaches across oncology and other therapeutic areas.
AI & Machine LearningBiotechWatertown, US
Peter Smith, PhD(Co-Founder, President and Chief Executive Officer)Peter Smith(Co-Founder, President and Chief Executive Officer)
Company that went public on NASDAQ in 2018 (RCUS)
ShapeTX develops programmable RNA medicines by combining artificial intelligence with RNA technology to address genetic causes of disease.
AI & Machine LearningBiotechDeep Tech
Josef von Rickenbach, PhD(Co-Founder)
Company that went public on NASDAQ in 2023 (SLRN)
Company that went public on NASDAQ in 2021 (TERN)
Public company trading on NASDAQ (ZNTL)
Frequently asked questions
- What stage does Decheng Capital invest at?
- Decheng Capital invests at the Seed, Growth stages.
- What sectors does Decheng Capital focus on?
- Decheng Capital focuses on Biotech, Healthtech, Medical Devices.
- Where is Decheng Capital located?
- Decheng Capital is headquartered in Silicon Valley, US.
Similar investors
Breyer Capital invests in breakthrough biomedical technologies, emerging models of care, and economic systems that drive sustainable healthcare transformation. The firm partners early and deeply with entrepreneurs across AI-first diagnostics, programmable medicines, data infrastructure, financial systems, clinician software, and novel care delivery models.
Data Collective identifies and supports ambitious company founders developing technology-driven solutions. The firm focuses on companies using innovation to restore predictability in an unstable world, with demonstrated expertise across clean energy, gene therapy, sustainable agriculture, and machine learning applications in healthcare.
Google Ventures invests in innovative founders across diverse industries, focusing on companies where they can provide value across multiple stages and milestones through long-term relationships.
Innovestor is a Nordic investment group active across early-stage platforms including Angel CoFund, Life Science Fund, and Growth Fund III. The firm completed 74 investments in 2025 (23 initial and 51 follow-on rounds) and achieved a €24 million real estate exit. Innovestor also operates Energy Storage and Corporate Venturing investment platforms.
ARTIS Ventures is a venture capital firm focused on investing in frontier technologies at the intersection of biology, healthcare, AI, and data. The firm backs companies spanning therapeutics, medical devices, diagnostics, and digital health, with recognition including Forbes Midas List and CB Insights Top 100 VC designation.